Clinical and economic aspects of managing venous thromboembolism in the outpatient setting

This publication has 47 references indexed in Scilit:

• A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
  New England Journal of Medicine, 1999
• Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement
  PharmacoEconomics, 1998
• Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
  New England Journal of Medicine, 1997
• Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis A feasibility and health economic study in an outpatient setting
  Journal of Internal Medicine, 1996
• Comparison of the Efficacy and Safety of Low Molecular Weight Heparins and Unfractionated Heparin in the Initial Treatment of Deep Venous Thrombosis
  Drugs, 1996
• Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality.
  BMJ, 1991
• Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
  BMJ, 1991
• Deep venous thrombosis: a continuing problem.
  BMJ, 1988
• Survey of Prophylaxis Against Venous Thromboembolism in Adults Undergoing Hip Surgery
  Clinical Orthopaedics and Related Research, 1987
• PREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN INJURED PATIENTS: A Trial of Anticoagulant Prophylaxis with Phenindione in Middle-aged and Elderly Patients with Fractured Necks of Femur
  The Lancet, 1959